LFWD
Lifeward Ltd.
Price Chart
Latest Quote
$6.80
-0.14 (-2.02%)
Current Price
| Previous Close | $6.94 |
| Open | $6.80 |
| Day High | $6.80 |
| Day Low | $6.80 |
| Volume | 935 |
Stock Information
| Shares Outstanding | 2.81M |
| Total Debt | $8.81M |
| Cash Equivalents | $11.42M |
| Revenue | $20.92M |
| Net Income | $-25.87M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $19.14M |
| EPS (TTM) | $-18.33 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $16.92M |
| Sales | $20.92M |
| Income | $-25.87M |
| Book/sh | $2.26 |
| Cash/sh | $4.06 |
| Employees | 81 |
Financial Ratios
| Quick Ratio | 1.61 |
| Current Ratio | 2.40 |
| Debt/Eq | 140.10 |
Returns & Margins
| ROA | -35.12% |
| ROE | -209.10% |
| Gross Margin | 36.55% |
| Operating Margin | -123.35% |
| Profit Margin | -123.66% |
Ownership
| Insider Ownership | 47.60% |
| Institutional Ownership | 0.79% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -3.82 |
| P/S | 0.91 |
| P/B | 3.00 |
Analyst Data
| Recommendation | none |
| Target Price | $20.00 |
Technical Indicators
| SMA20 | $7.16 |
| SMA50 | $7.03 |
| SMA200 | $7.26 |
| RSI | 38.36 |
| ATR | 0.3101 |
| Shares Float | 1.55M |
| Short Float | 4.41% |
| Short Ratio | 12.28 |
| Volatility | 0.37 |
| Rel Volume | 0.12 |
Performance History
| Week | -2.58% |
| Month | -2.58% |
| Quarter | +4.13% |
| 6 Months | -16.67% |
| YTD | -9.19% |
| Year | -41.46% |
| 3 Years | -86.33% |
| 5 Years | -95.48% |
| 10 Years | -99.95% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-25 | $6.80 | 935 |
| 2026-06-24 | $6.94 | 4,400 |
| 2026-06-23 | $6.95 | 6,800 |
| 2026-06-22 | $7.19 | 9,200 |
| 2026-06-18 | $6.91 | 2,600 |
| 2026-06-17 | $6.98 | 2,600 |
| 2026-06-16 | $6.91 | 3,900 |
| 2026-06-15 | $6.95 | 8,400 |
| 2026-06-12 | $6.78 | 5,500 |
| 2026-06-11 | $6.80 | 1,600 |
| 2026-06-10 | $7.07 | 6,200 |
| 2026-06-09 | $6.98 | 3,300 |
| 2026-06-08 | $6.98 | 7,700 |
| 2026-06-05 | $7.01 | 10,700 |
| 2026-06-04 | $7.17 | 4,900 |
| 2026-06-03 | $7.28 | 14,500 |
| 2026-06-02 | $7.68 | 13,700 |
| 2026-06-01 | $7.95 | 14,600 |
| 2026-05-29 | $7.94 | 6,800 |
| 2026-05-28 | $7.94 | 21,700 |
| 2026-05-27 | $7.50 | 20,500 |
| 2026-05-26 | $6.98 | 13,000 |
About Lifeward Ltd.
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal cord injury; ReStore Exo-Suit, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals' post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024. Lifeward Ltd. was incorporated in 2001 and is based in Yokneam Illit, Israel.
đ° Latest News
How The Lifeward (LFWD) Story Is Shifting With New Price Targets And Valuation Assumptions
Simply Wall St. âĸ 2026-05-17T13:13:59Z
Lifeward Ltd (LFWD) Q1 2026 Earnings Call Highlights: Navigating Challenges and Seizing Growth ...
GuruFocus.com âĸ 2026-05-15T23:01:29ZLifeward (LFWD) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-15T17:00:01Z
Lifeward Ltd. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-15T16:42:59Z
Lifeward (LFWD) Reports Q1 Loss, Lags Revenue Estimates
Zacks âĸ 2026-05-15T14:05:02Z
Keros Therapeutics, Inc. (KROS) Reports Q1 Loss, Misses Revenue Estimates
Zacks âĸ 2026-05-14T13:10:02Z
CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates
Zacks âĸ 2026-05-04T21:50:04Z
Lifeward Ltd (LFWD) Q4 2025 Earnings Call Highlights: Strategic Moves and Market Challenges
GuruFocus.com âĸ 2026-03-18T19:02:51ZLifeward: Q4 Earnings Snapshot
Associated Press Finance âĸ 2026-03-18T12:17:35ZLifeward Ltd (LFWD) Q4 2025: Everything You Need To Know Ahead Of Earnings
GuruFocus.com âĸ 2026-03-17T13:24:22Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $13,606,000 | $17,447,000 | $9,401,000 | $3,606,000 |
| Cost Of Revenue | $13,606,000 | $17,447,000 | $9,401,000 | $3,606,000 |
| Total Revenue | $22,034,000 | $25,663,000 | $13,854,000 | $5,511,000 |
| Operating Revenue | $22,034,000 | $25,663,000 | $13,854,000 | $5,511,000 |
| Expenses | ||||
| Total Expenses | $38,925,000 | $45,216,000 | $37,466,000 | $24,613,000 |
| Other Income Expense | $-2,641,000 | $-9,861,000 | $133,000 | $22,000 |
| Net Non Operating Interest Income Expense | $-437,000 | $515,000 | $1,334,000 | $-22,000 |
| Total Other Finance Cost | $437,000 | $-515,000 | $-1,334,000 | $22,000 |
| Operating Expense | $25,319,000 | $27,769,000 | $28,065,000 | $21,007,000 |
| Selling And Marketing Expense | $13,875,000 | $17,949,000 | $13,922,000 | $9,842,000 |
| General And Administrative Expense | $8,195,000 | $5,195,000 | $9,995,000 | $7,134,000 |
| Interest Expense | - | - | - | $0 |
| Interest Expense Non Operating | - | - | - | $0 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-19,914,000 | $-28,942,000 | $-22,133,000 | $-19,569,000 |
| Net Interest Income | $-437,000 | $515,000 | $1,334,000 | $-22,000 |
| Normalized Income | $-17,280,923 | $-21,151,810 | $-22,265,928 | $-19,586,380 |
| Net Income From Continuing And Discontinued Operation | $-19,914,000 | $-28,942,000 | $-22,133,000 | $-19,569,000 |
| Total Operating Income As Reported | $-19,674,000 | $-29,347,000 | $-23,612,000 | $-19,102,000 |
| Net Income Common Stockholders | $-19,914,000 | $-28,942,000 | $-22,133,000 | $-19,569,000 |
| Net Income | $-19,914,000 | $-28,942,000 | $-22,133,000 | $-19,569,000 |
| Net Income Including Noncontrolling Interests | $-19,914,000 | $-28,942,000 | $-22,133,000 | $-19,569,000 |
| Net Income Continuous Operations | $-19,914,000 | $-28,942,000 | $-22,133,000 | $-19,569,000 |
| Pretax Income | $-19,969,000 | $-28,899,000 | $-22,145,000 | $-19,102,000 |
| Special Income Charges | $-2,783,000 | $-9,794,000 | $0 | $0 |
| Operating Income | $-16,891,000 | $-19,553,000 | $-23,612,000 | $-19,102,000 |
| Gross Profit | $8,428,000 | $8,216,000 | $4,453,000 | $1,905,000 |
| Interest Income | - | $643,000 | $1,354,000 | $0 |
| Interest Income Non Operating | - | $643,000 | $1,354,000 | $0 |
| Per Share | ||||
| Diluted EPS | $-17.16 | $-39.96 | $-31.13 | $-26.35 |
| Basic EPS | $-17.16 | $-39.96 | $-31.08 | $-26.04 |
| Other | ||||
| Tax Effect Of Unusual Items | $-7,923 | $-2,070,810 | $72 | $4,620 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-13,917,000 | $-5,851,000 | $-21,898,000 | $-18,922,000 |
| Total Unusual Items | $-2,641,000 | $-9,861,000 | $133,000 | $22,000 |
| Total Unusual Items Excluding Goodwill | $-2,641,000 | $-9,861,000 | $133,000 | $22,000 |
| Reconciled Depreciation | $333,000 | $3,841,000 | $1,847,000 | $202,000 |
| EBITDA (Bullshit earnings) | $-16,558,000 | $-15,712,000 | $-21,765,000 | $-18,900,000 |
| EBIT | $-16,891,000 | $-19,553,000 | $-23,612,000 | $-19,102,000 |
| Diluted Average Shares | $1,160,521 | $724,272 | $710,941 | $742,604 |
| Basic Average Shares | $1,160,521 | $724,272 | $710,941 | $742,604 |
| Diluted NI Availto Com Stockholders | $-19,914,000 | $-28,942,000 | $-22,133,000 | $-19,569,000 |
| Tax Provision | $-55,000 | $43,000 | $-12,000 | $467,000 |
| Impairment Of Capital Assets | $2,783,000 | $9,794,000 | $0 | $0 |
| Gain On Sale Of Security | $142,000 | $-67,000 | $133,000 | $22,000 |
| Research And Development | $3,249,000 | $4,625,000 | $4,148,000 | $4,031,000 |
| Selling General And Administration | $22,070,000 | $23,144,000 | $23,917,000 | $16,976,000 |
| Other Gand A | $8,195,000 | $5,195,000 | $9,995,000 | $7,134,000 |
| Write Off | - | $9,794,000 | $0 | $0 |
Fetched: 2026-06-23
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $3,653,000 | $11,311,000 | $26,447,000 | $68,165,000 |
| Total Assets | $22,900,000 | $30,487,000 | $63,192,000 | $74,236,000 |
| Total Non Current Assets | $7,093,000 | $9,193,000 | $23,970,000 | $1,726,000 |
| Other Non Current Assets | $209,000 | $240,000 | $784,000 | $694,000 |
| Goodwill And Other Intangible Assets | $4,755,000 | $7,538,000 | $20,063,000 | $0 |
| Current Assets | $15,807,000 | $21,294,000 | $39,222,000 | $72,510,000 |
| Other Current Assets | $611,000 | $578,000 | $1,000,000 | $233,000 |
| Restricted Cash | $240,000 | $197,000 | $0 | - |
| Prepaid Assets | $917,000 | $1,046,000 | $1,366,000 | $416,000 |
| Inventory | $5,732,000 | $6,723,000 | $5,653,000 | $2,929,000 |
| Receivables | $6,138,000 | $6,004,000 | $3,120,000 | $1,036,000 |
| Accounts Receivable | $6,138,000 | $6,004,000 | $3,120,000 | $1,036,000 |
| Allowance For Doubtful Accounts Receivable | $-192,000 | $-160,000 | $-328,000 | $-26,000 |
| Gross Accounts Receivable | $6,330,000 | $6,164,000 | $3,448,000 | $1,062,000 |
| Cash Cash Equivalents And Short Term Investments | $2,169,000 | $6,746,000 | $28,083,000 | $67,896,000 |
| Cash And Cash Equivalents | $2,169,000 | $6,746,000 | $28,083,000 | $67,896,000 |
| Other Intangible Assets | - | - | $12,525,000 | - |
| Debt | ||||
| Net Debt | $634,000 | - | - | - |
| Total Debt | $4,387,000 | $880,000 | $1,903,000 | $897,000 |
| Long Term Debt And Capital Lease Obligation | $1,159,000 | $22,000 | $607,000 | $333,000 |
| Current Debt And Capital Lease Obligation | $3,228,000 | $858,000 | $1,296,000 | $564,000 |
| Current Debt | $2,803,000 | - | - | - |
| Other Current Borrowings | $2,803,000 | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $14,492,000 | $11,638,000 | $16,682,000 | $6,071,000 |
| Total Non Current Liabilities Net Minority Interest | $2,453,000 | $1,413,000 | $4,887,000 | $1,289,000 |
| Other Non Current Liabilities | $61,000 | $67,000 | $2,774,000 | $66,000 |
| Non Current Deferred Liabilities | $1,233,000 | $1,324,000 | $1,506,000 | $890,000 |
| Current Liabilities | $12,039,000 | $10,225,000 | $11,795,000 | $4,782,000 |
| Other Current Liabilities | $859,000 | $1,765,000 | $1,892,000 | $685,000 |
| Current Deferred Liabilities | $920,000 | $1,248,000 | $1,504,000 | $301,000 |
| Payables And Accrued Expenses | $7,032,000 | $6,354,000 | $7,103,000 | $3,232,000 |
| Payables | $5,590,000 | $5,022,000 | $5,069,000 | $1,950,000 |
| Accounts Payable | $5,590,000 | $5,022,000 | $5,069,000 | $1,950,000 |
| Equity | ||||
| Common Stock Equity | $8,408,000 | $18,849,000 | $46,510,000 | $68,165,000 |
| Total Equity Gross Minority Interest | $8,408,000 | $18,849,000 | $46,510,000 | $68,165,000 |
| Stockholders Equity | $8,408,000 | $18,849,000 | $46,510,000 | $68,165,000 |
| Retained Earnings | $-284,739,000 | $-264,825,000 | $-235,883,000 | $-213,750,000 |
| Other | ||||
| Treasury Shares Number | $47,887 | $47,888 | $47,888 | $34,919 |
| Ordinary Shares Number | $1,524,430 | $734,011 | $715,596 | $715,360 |
| Share Issued | $1,572,317 | $781,899 | $763,484 | $750,279 |
| Tangible Book Value | $3,653,000 | $11,311,000 | $26,447,000 | $68,165,000 |
| Invested Capital | $11,211,000 | $18,849,000 | $46,510,000 | $68,165,000 |
| Working Capital | $3,768,000 | $11,069,000 | $27,427,000 | $67,728,000 |
| Capital Lease Obligations | $1,584,000 | $880,000 | $1,903,000 | $897,000 |
| Total Capitalization | $8,408,000 | $18,849,000 | $46,510,000 | $68,165,000 |
| Treasury Stock | $3,203,000 | $3,203,000 | $3,203,000 | $2,431,000 |
| Additional Paid In Capital | $286,932,000 | $282,287,000 | $281,109,000 | $279,857,000 |
| Capital Stock | $9,418,000 | $4,590,000 | $4,487,000 | $4,489,000 |
| Common Stock | $9,418,000 | $4,590,000 | $4,487,000 | $4,489,000 |
| Non Current Deferred Revenue | $1,233,000 | $1,324,000 | $1,506,000 | $890,000 |
| Long Term Capital Lease Obligation | $1,159,000 | $22,000 | $607,000 | $333,000 |
| Current Deferred Revenue | $920,000 | $1,248,000 | $1,504,000 | $301,000 |
| Current Capital Lease Obligation | $425,000 | $858,000 | $1,296,000 | $564,000 |
| Current Accrued Expenses | $1,442,000 | $1,332,000 | $2,034,000 | $1,282,000 |
| Goodwill | $4,755,000 | $7,538,000 | $7,538,000 | $0 |
| Net PPE | $2,129,000 | $1,415,000 | $3,123,000 | $1,032,000 |
| Accumulated Depreciation | $-7,311,000 | $-7,034,000 | $-6,341,000 | $-3,625,000 |
| Gross PPE | $9,440,000 | $8,449,000 | $9,464,000 | $4,657,000 |
| Leases | $658,000 | $658,000 | $658,000 | $333,000 |
| Other Properties | $5,986,000 | $5,012,000 | $6,027,000 | $2,652,000 |
| Machinery Furniture Equipment | $2,796,000 | $2,779,000 | $2,779,000 | $1,672,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $3,689,000 | $3,580,000 | $3,157,000 | $2,421,000 |
| Work In Process | $38,000 | $0 | - | - |
| Raw Materials | $2,005,000 | $3,143,000 | $2,496,000 | $508,000 |
| Pensionand Other Post Retirement Benefit Plans Current | - | - | $2,034,000 | $1,282,000 |
Fetched: 2026-06-23
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-16,842,000 | $-21,718,000 | $-20,748,000 | $-17,916,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-16,826,000 | $-21,718,000 | $-20,667,000 | $-17,891,000 |
| Cash Flow From Continuing Operating Activities | $-16,826,000 | $-21,718,000 | $-20,667,000 | $-17,891,000 |
| Operating Gains Losses | $-307,000 | $-34,000 | $-45,000 | $79,000 |
| Investing Activities | ||||
| Capital Expenditure | $-16,000 | - | $-81,000 | $-25,000 |
| Investing Cash Flow | $-16,000 | $0 | $-18,149,000 | $-25,000 |
| Cash Flow From Continuing Investing Activities | $-16,000 | $0 | $-18,149,000 | $-25,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $0 | $0 | $-992,000 | $-2,500,000 |
| Issuance Of Capital Stock | $9,203,000 | $0 | $0 | $0 |
| Financing Cash Flow | $12,203,000 | $0 | $-992,000 | $-2,500,000 |
| Cash Flow From Continuing Financing Activities | $12,203,000 | $0 | $-992,000 | $-2,500,000 |
| Net Other Financing Charges | $1,563,000 | - | - | - |
| Net Common Stock Issuance | $9,203,000 | $0 | $-992,000 | $-2,500,000 |
| Common Stock Issuance | $9,203,000 | $0 | $0 | $0 |
| Other | ||||
| Issuance Of Debt | $1,437,000 | $0 | $0 | $0 |
| End Cash Position | $2,579,000 | $7,108,000 | $28,792,000 | $68,555,000 |
| Beginning Cash Position | $7,108,000 | $28,792,000 | $68,555,000 | $89,050,000 |
| Effect Of Exchange Rate Changes | $110,000 | $34,000 | $45,000 | $-79,000 |
| Changes In Cash | $-4,639,000 | $-21,718,000 | $-39,808,000 | $-20,416,000 |
| Common Stock Payments | $0 | $0 | $-992,000 | $-2,500,000 |
| Net Issuance Payments Of Debt | $1,437,000 | $0 | $0 | $0 |
| Net Short Term Debt Issuance | $1,437,000 | $0 | $0 | - |
| Short Term Debt Issuance | $1,437,000 | $0 | $0 | - |
| Net Business Purchase And Sale | $0 | $0 | $-18,068,000 | $0 |
| Purchase Of Business | $0 | $0 | $-18,068,000 | $0 |
| Net PPE Purchase And Sale | $-16,000 | $0 | $-81,000 | $-25,000 |
| Purchase Of PPE | $-16,000 | $0 | $-81,000 | $-25,000 |
| Change In Working Capital | $-298,000 | $-4,974,000 | $-1,338,000 | $88,000 |
| Change In Other Working Capital | $-419,000 | $-438,000 | $-269,000 | $-34,000 |
| Change In Other Current Liabilities | $-1,035,000 | $-1,366,000 | $-973,000 | $-153,000 |
| Change In Other Current Assets | $439,000 | $1,195,000 | $125,000 | - |
| Change In Payables And Accrued Expense | $-237,000 | $-749,000 | $1,023,000 | $706,000 |
| Change In Accrued Expense | $110,000 | $-702,000 | $-14,000 | $140,000 |
| Change In Payable | $-347,000 | $-47,000 | $1,037,000 | $566,000 |
| Change In Account Payable | $-347,000 | $-47,000 | $1,037,000 | $566,000 |
| Change In Prepaid Assets | $192,000 | $188,000 | $-656,000 | $94,000 |
| Change In Inventory | $896,000 | $-920,000 | $-277,000 | $-117,000 |
| Change In Receivables | $-134,000 | $-2,884,000 | $-311,000 | $-408,000 |
| Changes In Account Receivables | $-134,000 | $-2,884,000 | $-311,000 | $-408,000 |
| Other Non Cash Items | $-166,000 | $-2,684,000 | $-326,000 | - |
| Stock Based Compensation | $743,000 | $1,281,000 | $1,328,000 | $993,000 |
| Asset Impairment Charge | $2,783,000 | $9,794,000 | $0 | $0 |
| Depreciation Amortization Depletion | $333,000 | $3,841,000 | $1,847,000 | $202,000 |
| Depreciation And Amortization | $333,000 | $3,841,000 | $1,847,000 | $202,000 |
| Amortization Cash Flow | $0 | $3,347,000 | $1,608,000 | $0 |
| Amortization Of Intangibles | $0 | $3,347,000 | $1,608,000 | $0 |
| Depreciation | $333,000 | $494,000 | $239,000 | $202,000 |
| Gain Loss On Investment Securities | $-197,000 | - | - | - |
| Net Foreign Currency Exchange Gain Loss | $-110,000 | $-34,000 | $-45,000 | $79,000 |
| Net Income From Continuing Operations | $-19,914,000 | $-28,942,000 | $-22,133,000 | $-19,569,000 |
| Deferred Tax | - | $0 | $0 | $316,000 |
| Deferred Income Tax | - | $0 | $0 | $316,000 |
| Interest Paid Supplemental Data | - | - | $1,341,000 | $0 |
| Income Tax Paid Supplemental Data | - | - | $126,000 | $113,000 |
| Proceeds From Stock Option Exercised | - | - | $0 | $0 |
| Repayment Of Debt | - | - | - | $0 |
| Net Long Term Debt Issuance | - | - | - | $0 |
| Long Term Debt Payments | - | - | - | $0 |
| Long Term Debt Issuance | - | - | - | $0 |
Fetched: 2026-06-23